Background: In Cameroon, little is known about the visual repercussions of neurological disorders, according to the available literature. Local data could improve screening, prevention, and treatment, particularly at Douala General Hospital (DGH). This study aimed to analyze this association within the ophthalmology unit of the DGH. Methods: We conducted a retrospective study at the ophthalmology department of Douala General Hospital over five years (2015-2020), including 77 patients. Sociodemographic data, medical history, ophthalmological causes of visual acuity decline, as well as neurological manifestations and aetiologias, were collected from patient records. Statistical analysis, performed using R software, employed binomial logistic regression to calculate odds ratios (OR), confidence intervals (CI), and p-values, identifying neurological disorders associated with visual impairments. Results: The mean age of the patients was 59.38 ± 18.15 years. The most represented age group was 70 - 91 years (36.4%). Females were predominant (male-to-female ratio: 0.87). A total of 44 (57.14%) patients presented with vision impairments. The main neurological aetiologias were ischemic stroke (58.4%), hemorrhagic stroke (19.5%), and epilepsy (11.7%). Neurological disorders associated with visual function abnormalities included hemorrhagic stroke (OR = 3.75; 95% CI: 1.96 - 14.61; p = 0.02), Devic’s disease (OR = 3.20; 95% CI: 1.34 - 30.06; p = 0.001), and migraines (OR = 2.52; 95% CI: 1.3 - 17.55; p = 0.003). Conclusion: Neurological disorders such as hemorrhagic stroke, Devic’s disease, and migraines are associated with visual function impairment.
References
[1]
Pizzarello, L., Abiose, A., Ffytche, T., et al. (2004) VISION 2020: The Right to Sight. Archives of Ophthalmology, 122, 615-620. https://doi.org/10.1001/archopht.122.4.615
[2]
Pascolini, D. and Mariotti, S.P. (2011) Global Estimates of Visual Impairment: 2010. BritishJournalofOphthalmology, 96, 614-618. https://doi.org/10.1136/bjophthalmol-2011-300539
[3]
Rupert, R.A.B., Seth, R.F., Tasanee, B., Maria, V.C., Aditi, D., et al. (2017) Magnitude, Temporal Trends, and Projections of the Global Prevalence of Blindness and Distance and Near Vision Impairment: A Systematic Review and Meta-Analysis. The Lancet Global Health, 5, e888-e897.
[4]
Kocur, I. and Resnikoff, S. (2002) Visual Impairment and Blindness in Europe and Their Prevention. BritishJournalofOphthalmology, 86, 716-722. https://doi.org/10.1136/bjo.86.7.716
[5]
Zhang, B., Xu, M., Wang, Q., Zhang, X., Liu, B., Li, M., et al. (2024) The Relationship between Illness Perception and Vision-Related Quality of Life among Chinese Patients with Diabetic Retinopathy: The Mediating Role of Resignation Coping Style. BMCOphthalmology, 24, Article No. 499. https://doi.org/10.1186/s12886-024-03762-6
[6]
Cao, G., Chen, Z., Yao, S., Wang, K., Huang, Z., Su, H., et al. (2022) The Association between Vision Impairment and Cognitive Outcomes in Older Adults: A Systematic Review and Meta-Analysis. Aging&MentalHealth, 27, 350-356. https://doi.org/10.1080/13607863.2022.2077303
[7]
Rowe, F.J. (2017) Vision in Stroke Cohort: Profile Overview of Visual Impairment. BrainandBehavior, 7, e00771. https://doi.org/10.1002/brb3.771
[8]
Mao, L., Yu, Z., Lin, L., Sharma, M., Song, H., Zhao, H. and Xu, X. (2024) Determinants of Visual Impairment among Chinese Middle-Aged and Older Adults: Risk Prediction Model Using Machine Learning Algorithms. JMIR Aging, 7, e59810.
[9]
Balcer, L.J., Miller, D.H., Reingold, S.C. and Cohen, J.A. (2014) Vision and Vision-Related Outcome Measures in Multiple Sclerosis. Brain, 138, 11-27. https://doi.org/10.1093/brain/awu335
[10]
Archibald, N.K., Clarke, M.P., Mosimann, U.P. and Burn, D.J. (2009) The Retina in Parkinson's Disease. Brain, 132, 1128-1145. https://doi.org/10.1093/brain/awp068
[11]
Bodis-Wollner, I. (2009) Retinopathy in Parkinson Disease. JournalofNeuralTransmission, 116, 1493-1501. https://doi.org/10.1007/s00702-009-0292-z
[12]
Zhu, Z., Hu, W., Liao, H., Tan, Z., Chen, Y., Shi, D., et al. (2021) Association of Visual Impairment with Risk for Future Parkinson's Disease. eClinicalMedicine, 42, Article ID: 101189. https://doi.org/10.1016/j.eclinm.2021.101189
[13]
Masters, B.R. (2014) The New Visual Neurosciences. Eds: John S. Werner and Leo M. Chalupa ISBN-13: 978-0-262-01916-3 the MIT Press. Graefe’sArchiveforClinicalandExperimentalOphthalmology, 252, 1341-1343. https://doi.org/10.1007/s00417-014-2661-z
[14]
Shi, H., Koronyo, Y., Rentsendorj, A., Fuchs, D., Sheyn, J., Black, K.L., et al. (2021) Retinal Vasculopathy in Alzheimer’s Disease. FrontiersinNeuroscience, 15, Article 731614. https://doi.org/10.3389/fnins.2021.731614
[15]
World Health Organisation (2018) Classification of Diseases (ICD). Report of WHO Consultation. WHO. https://www.who.int/standards/classifications/classification-of-diseases
[16]
Bouscaren, N., Kacem, M.A. and Mghirbi, S. (2019) Association between Aging and Visual Impairment in Neurological Diseases: A Study in Tunisia. Neuroophthalmology, 43, 16-24.
[17]
Adeoye, A. and Bowman, F. (2018) Prevalence of Neurological Disorders in African Populations: A Systematic Review. African Journal of Neurology, 12, 45-59.
[18]
Ayedun, C.A., Olatunji, A.O. and Sulaimon, T.A. (2020) Gender Differences in Neurological and Visual Health among Elderly Populations in Sub-Saharan Africa. Journal of Aging and Health, 32, 821-834.
[19]
Petersen, R.C., Lopez, O. and Armstrong, M. (2016) Prevalence of Alzheimer’s Dis-ease and Other Dementias in Women: A Review. Journal of Neurology, 263, 1032-1040.
[20]
Nguefack, M.S., Kengne, A.P. and Bessala, M. (2021) Visual Disorders in Elderly Patients with Neurological Diseases in Cameroon: A Hospital-Based Study. Journal of Ophthalmic Research, 29, 235-241.
[21]
World Health Organization (2017) Global Strategy and Action Plan on Ageing and Health. World Health Organization. https://www.who.int/publications/i/item/9789241513500
Smith, J.A., Modisane, S. and Molefe, P. (2020) Vision Impairment among Patients with Neurological Disorders in South Africa. African Journal of Ophthalmology, 38, 152-160.
[24]
Mapoure, N.Y., Doumbe, J.I., Massi, D.G., Nynyikua, N.T., Kuate, T.C. and Luma, N.H. (2018) Epidémiologie clinique des affections neurologiques dans la ville de Douala. Revue de Médecine et de Pharmacie, 8, 738-750.
[25]
Pula, J.H. and Yuen, C.A. (2017) Eyes and Stroke: The Visual Aspects of Cerebrovascular Disease. StrokeandVascularNeurology, 2, 210-220. https://doi.org/10.1136/svn-2017-000079
[26]
Rowe, F.J., Hepworth, L.R., Howard, C., Hanna, K.L. and Currie, J. (2020) Impact of Visual Impairment Following Stroke (IVIS Study): A Prospective Clinical Profile of Central and Peripheral Visual Deficits, Eye Movement Abnormalities and Visual Perceptual Deficits. DisabilityandRehabilitation, 44, 3139-3153. https://doi.org/10.1080/09638288.2020.1859631
[27]
Jarius, S., Aktas, O., Ayzenberg, I., Bellmann-Strobl, J., Berthele, A., Giglhuber, K., et al. (2023) Update on the Diagnosis and Treatment of Neuromyelits Optica Spectrum Disorders (NMOSD)—Revised Recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and Differential Diagnosis. JournalofNeurology, 270, 3341-3368. https://doi.org/10.1007/s00415-023-11634-0
